시장보고서
상품코드
1699093

후생유전학 시장 분석 및 예측(-2034년) : 유형, 제품, 서비스, 기술, 용도, 최종사용자, 구성요소, 디바이스

Epigenetics Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Application, End User, Component, Device

발행일: | 리서치사: Global Insight Services | 페이지 정보: 영문 445 Pages | 배송안내 : 3-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

후생유전학 시장은 2024년 18억 달러에서 2034년까지 약 18.5%의 연평균 성장률(CAGR)로 98억 달러로 확대될 것으로 예측됩니다. 이 시장에는 DNA 염기서열의 변화를 수반하지 않는 유전자 발현의 변화를 연구하는 기술과 서비스가 포함됩니다. 이 분야에는 DNA 메틸화, 히스톤 변형, RNA 관련 사이렌싱 등이 포함됩니다. 응용 분야는 종양학에서 심혈관질환에 이르기까지 다양하며, 이는 만성질환의 유병률 증가와 맞춤형 의료의 발전이 원동력이 되고 있습니다. 생명공학 분야의 연구 활동과 투자 증가로 인해 시장은 성장할 것으로 예상되며, 진단 및 치료 분야에서 혁신의 기회를 제공하고 있습니다.

시장 개요:

후생유전학 시장은 맞춤형 의료의 발전과 만성질환의 유병률 증가로 인해 확대되고 있습니다. 연구 및 진단에서 중요한 역할을 하는 시약 부문이 우위를 점하고 있습니다. 항체, PCR 시약, 히스톤과 같은 시약은 후생유전학 변형 및 분석에 필수적이며, 연구기관 및 제약회사의 높은 수요를 반영하고 있습니다. 시약 처방의 기술 혁신은 특이성과 효율성을 높이고 시장 우위를 강화하고 있습니다. 차세대 시퀀서 및 질량 분석기를 포함한 기기 부문은 정확한 후생유전학적 프로파일링을 촉진하는 기술 발전으로 인해 근소한 차이로 뒤를 잇고 있습니다. 후생유전학 연구에서 강력한 데이터 분석 및 해석의 필요성에 따라 바이오인포매틱스 툴과 같은 새로운 하위 부문이 성장세를 보이고 있습니다. 이러한 도구는 복잡한 데이터세트를 관리하는 데 매우 중요하며, 유전자 발현 패턴과 잠재적 치료 표적에 대한 인사이트를 제공합니다. 바이오인포매틱스와 인공지능의 통합은 예측 분석을 강화하고 신약 개발 과정을 가속화하여 시장에 혁명을 일으킬 준비가 되어 있습니다.

시장 세분화
유형 DNA 메틸화, 히스톤 변형, 비코딩 RNA, 크로마틴 리모델링, 후성유전체 효소, 후성유전체 리더, 후성유전체 라이터, 후성유전체 지우기
제품 시약, 키트, 기기, 효소, 항체, 소프트웨어
서비스 후성유전체 염기서열 분석, DNA 메틸화 분석, 크로마틴 면역침강, 바이오인포매틱스 솔루션, 컨설팅 서비스
기술 차세대 시퀀싱, 중합효소 연쇄 반응, 질량분석, 크로마틴 분석, 마이크로어레이
용도 종양학, 심혈관질환, 대사성 질환, 신경퇴행성 질환, 면역학, 발생생물학
최종사용자 학술연구기관, 제약회사, 생명공학기업, 위탁연구기관, 임상실험실
구성요소 어세이 키트, 시약 키트, 항체
디바이스 분석 기기, 시퀀싱 플랫폼

후생유전학 시장에서는 표적치료 및 맞춤의료에 대한 수요 증가로 인해 제약 및 생명공학 분야가 가장 큰 시장 점유율을 차지하고 있습니다. 학술 및 연구기관 부문은 후생유전학 연구 및 혁신에 대한 자금 조달이 급증함에 따라 그 뒤를 잇고 있습니다. 지역별로는 북미가 탄탄한 연구 활동과 선진화된 헬스케어 인프라로 우위를 점하고 있는 반면, 아시아태평양은 의료 투자 증가와 정밀의료의 급격한 성장으로 인해 빠른 성장세를 보이고 있습니다. 경쟁 환경은 Illumina, Thermo Fisher Scientific, Merck 등 전략적 제휴 및 인수를 통해 지속적으로 포트폴리오를 강화하는 선도 기업들이 특징적입니다. 특히 미국과 유럽의 규제 프레임워크는 시장 역학을 형성하는 데 있어 매우 중요하며, 엄격한 가이드라인이 혁신을 촉진하고 품질을 보장하고 있습니다. 향후 후생유전학 기술의 발전과 종양학 및 만성질환 관리 분야에서의 응용이 증가함에 따라 시장은 크게 성장할 것으로 예상됩니다. 높은 비용과 윤리적 고려사항 등의 문제가 있지만, 후생유전학 연구에서의 인공지능과 기계학습의 통합은 향후 확장에 큰 기회를 제공할 것입니다.

주요 동향과 촉진요인:

후생유전학 시장은 기술 발전, 암 유병률 증가, R&D 투자 증가로 인해 강력한 성장세를 보이고 있습니다. 주요 동향으로는 후생유전학 연구에 인공지능과 머신러닝이 통합되어 데이터 분석의 정확성과 속도가 향상되고 있는 것을 들 수 있습니다. 맞춤형 의료의 채택도 증가하고 있으며, 후생유전학적 바이오마커는 환자 맞춤형 치료에 중요한 역할을 하고 있습니다. 질병 예방과 관리에 있어 후생유전학의 역할에 대한 인식이 높아진 것이 시장 촉진요인으로 작용하고 있습니다. 환경적 요인이 유전자 발현에 미치는 영향에 대한 이해도가 높아짐에 따라, 헬스케어 분야에서 후생유전학 솔루션에 대한 수요가 증가하고 있습니다. 또한, 학술 기관과 생명공학 기업 간의 협업은 혁신을 촉진하고 후생유전학의 적용 범위를 확장하고 있습니다. 제약 업계는 후생유전학 의약품 개발에 점점 더 많은 노력을 기울이고 있으며, 이는 시장 참여자들에게 유리한 기회를 창출하고 있습니다. 비침습적 진단 기술에 대한 수요도 시장을 발전시키고 있습니다. 규제 기관이 보다 유리한 가이드라인을 제공함에 따라 시장 진입이 보다 원활해져 신규 진입과 투자를 촉진하고 있습니다. 이러한 역동적인 트렌드와 촉진요인으로 인해 후생유전학 시장은 지속적으로 확대될 준비가 되어 있습니다.

억제요인과 과제:

후생유전학 시장은 몇 가지 주목할 만한 억제요인과 과제를 극복해 나가고 있습니다. 중요한 장애물은 후생유전학 연구와 기술에 대한 높은 비용으로 인해 첨단 도구와 방법에 대한 접근을 제한하고 있다는 점입니다. 이러한 경제적 장벽은 첨단 연구를 위한 자금이 부족한 개발도상국에서 특히 두드러집니다. 또한, 후생유전학의 메커니즘이 복잡하고 전문적인 지식이 필요하기 때문에 아직 의료진에게 널리 보급되지 않아 채택률이 낮습니다. 또한, 후생유전학적 치료제와 진단약은 엄격한 승인 절차를 거쳐야 하기 때문에 시장 진입을 지연시킬 수 있는 규제적 장애물이 존재하고 있습니다. 또한, 유전자 변형 및 유전자 조작에 대한 윤리적 우려는 일반 대중의 수용을 방해하고 감시를 강화할 수 있습니다. 마지막으로, 이 분야는 빠르게 발전하고 있기 때문에 연구개발에 대한 지속적인 투자가 필요하며, 이는 자원을 압박하고 신흥 혁신가보다 기존 플레이어를 우대하는 경쟁 환경을 조성할 수 있습니다. 이러한 과제들이 종합적으로 후생유전학 시장의 궤도를 형성하고 있습니다.

목차

제1장 후생유전학 시장 개요

  • 조사 목적
  • 후생유전학 시장 정의와 조사 범위
  • 보고서 제한
  • 조사 대상 연도·통화
  • 조사 방법

제2장 주요 요약

제3장 시장에 관한 주요 인사이트

제4장 후생유전학 시장 전망

  • 후생유전학 시장 세분화
  • 시장 역학
  • Porter's Five Forces 분석
  • PESTLE 분석
  • 밸류체인 분석
  • 4P 모델
  • ANSOFF 매트릭스

제5장 후생유전학 시장 전략

  • 상부 시장 분석
  • 수급 분석
  • 소비자 구매 의욕
  • 사례 연구 분석
  • 가격 분석
  • 규제 상황
  • 공급망 분석
  • 경쟁 제품 분석
  • 최근 동향

제6장 후생유전학 시장 규모

  • 후생유전학 시장 규모 : 금액별
  • 후생유전학 시장 규모 : 수량별

제7장 후생유전학 시장 : 유형별

  • 시장 개요
  • DNA 메틸화
  • 히스톤 변형
  • 논코딩 RNA
  • 크로마틴 리모델링
  • 에피제네틱 효소
  • 에피제네틱 리더
  • 에피제네틱 라이터
  • 에피제네틱 지우기
  • 기타

제8장 후생유전학 시장 : 제품별

  • 시장 개요
  • 시약
  • 키트
  • 기기
  • 효소
  • 항체
  • 소프트웨어
  • 기타

제9장 후생유전학 시장 : 서비스별

  • 시장 개요
  • 후생유전학 시퀀싱
  • DNA 메틸화 해석
  • 크로마틴 면역침강
  • 바이오인포매틱스 솔루션
  • 컨설팅 서비스
  • 기타

제10장 후생유전학 시장 : 기술별

  • 시장 개요
  • 차세대 시퀀싱
  • 중합효소 연쇄 반응
  • 질량 분석
  • 크로마틴 해석
  • 마이크로어레이
  • 기타

제11장 후생유전학 시장 : 용도별

  • 시장 개요
  • 암영역
  • 심혈관질환
  • 대사성 질환
  • 신경변성질환
  • 면역학
  • 발생생물학
  • 기타

제12장 후생유전학 시장 : 최종사용자별

  • 시장 개요
  • 학술연구기관
  • 제약회사
  • 바이오테크놀러지 기업
  • 수탁연구기관
  • 임상 연구소
  • 기타

제13장 후생유전학 시장 : 구성요소별

  • 시장 개요
  • 어세이 키트
  • 시약 키트
  • 항체
  • 기타

제14장 후생유전학 시장 : 디바이스별

  • 시장 개요
  • 분석 기기
  • 시퀀싱 플랫폼
  • 기타

제15장 후생유전학 시장 : 지역별

  • 시장 개요
  • 북미
    • 미국
    • 캐나다
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 스페인
    • 이탈리아
    • 네덜란드
    • 스웨덴
    • 스위스
    • 덴마크
    • 핀란드
    • 러시아
    • 기타 유럽
  • 아시아태평양
    • 중국
    • 인도
    • 일본
    • 한국
    • 호주
    • 싱가포르
    • 인도네시아
    • 대만
    • 말레이시아
    • 기타 아시아태평양
  • 라틴아메리카
    • 브라질
    • 멕시코
    • 아르헨티나
    • 기타 라틴아메리카
  • 중동 및 아프리카
    • 사우디아라비아
    • 아랍에미리트
    • 남아프리카공화국
    • 기타 중동 및 아프리카

제16장 경쟁 구도

  • 개요
  • 시장 점유율 분석
  • 주요 기업의 포지셔닝
  • 경쟁 리더십 매핑
  • 벤더 벤치마킹
  • 개발 전략 벤치마킹

제17장 기업 개요

  • Zymo Research
  • Active Motif
  • New England Biolabs
  • Diagenode
  • Epigenomics
  • Abcam
  • Bio-Rad Laboratories
  • EpiGentek
  • Cell Signaling Technology
  • Selleck Chemicals
  • PerkinElmer
  • QIAGEN
  • Illumina
  • Meridian Bioscience
  • Promega Corporation
  • SABiosciences
  • Cayman Chemical
  • Takara Bio
  • Enzo Life Sciences
  • Novus Biologicals
ksm 25.05.07

Epigenetics Market is anticipated to expand from $1.8 billion in 2024 to $9.8 billion by 2034, growing at a CAGR of approximately 18.5%. The market encompasses technologies and services that study changes in gene expression not involving alterations to the DNA sequence. This field includes DNA methylation, histone modification, and RNA-associated silencing. Applications span from oncology to cardiovascular diseases, driven by the increasing prevalence of chronic conditions and advancements in personalized medicine. The market is poised for growth due to rising research activities and investments in biotechnology, offering opportunities for innovation in diagnostics and therapeutics.

Market Overview:

The Epigenetics Market is expanding, driven by advancements in personalized medicine and increasing prevalence of chronic diseases. The reagents segment dominates, attributed to its critical role in research and diagnostics. Reagents, including antibodies, PCR reagents, and histones, are essential for epigenetic modifications and analysis, reflecting the high demand from research institutions and pharmaceutical companies. Technological innovations in reagent formulations enhance specificity and efficiency, reinforcing their market dominance. The instruments segment, encompassing next-generation sequencing and mass spectrometry, follows closely due to technological advancements facilitating precise epigenetic profiling. Emerging sub-segments such as bioinformatics tools are gaining traction, driven by the need for robust data analysis and interpretation in epigenetic research. These tools are pivotal in managing complex datasets, offering insights into gene expression patterns and potential therapeutic targets. The integration of artificial intelligence in bioinformatics is poised to revolutionize the market, enhancing predictive analytics and accelerating drug discovery processes.

Market Segmentation
TypeDNA Methylation, Histone Modification, Non-coding RNA, Chromatin Remodeling, Epigenetic Enzymes, Epigenetic Readers, Epigenetic Writers, Epigenetic Erasers
ProductReagents, Kits, Instruments, Enzymes, Antibodies, Software
ServicesEpigenetic Sequencing, DNA Methylation Analysis, Chromatin Immunoprecipitation, Bioinformatics Solutions, Consulting Services
TechnologyNext-Generation Sequencing, Polymerase Chain Reaction, Mass Spectrometry, Chromatin Analysis, Microarray
ApplicationOncology, Cardiovascular Diseases, Metabolic Diseases, Neurodegenerative Diseases, Immunology, Developmental Biology
End UserAcademic Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Clinical Research Laboratories
ComponentAssay Kits, Reagent Kits, Antibodies
DeviceAnalytical Instruments, Sequencing Platforms

In the epigenetics market, the pharmaceutical and biotechnology sectors command the most significant market share, driven by the increasing demand for targeted therapies and personalized medicine. The academic and research institutions segment follows, propelled by a surge in funding for epigenetic research and innovations. Geographically, North America dominates due to robust research activities and advanced healthcare infrastructure, while the Asia-Pacific region is witnessing accelerated growth driven by rising healthcare investments and a burgeoning focus on precision medicine. The competitive landscape is marked by prominent players such as Illumina, Thermo Fisher Scientific, and Merck, which are continuously enhancing their portfolios through strategic collaborations and acquisitions. Regulatory frameworks, particularly in the U.S. and Europe, are pivotal in shaping market dynamics, with stringent guidelines fostering innovation and ensuring quality. Looking ahead, the market is poised for substantial growth, fueled by advancements in epigenetic technologies and increasing applications in oncology and chronic disease management. Despite challenges such as high costs and ethical considerations, the integration of artificial intelligence and machine learning in epigenetic research presents significant opportunities for future expansion.

Geographical Overview:

The epigenetics market is experiencing notable growth across various regions, each characterized by unique dynamics. North America leads, driven by extensive research activities and significant investments in biotechnology. This region benefits from the presence of leading academic institutions and research organizations, which are pivotal in advancing epigenetic research. Europe follows, with a strong focus on personalized medicine and precision healthcare. The region's regulatory frameworks support innovation, fostering a conducive environment for epigenetics research and development. In Asia Pacific, the market is expanding rapidly due to increasing awareness and government initiatives supporting biotechnology advancements. Countries like China and India are investing heavily in research infrastructure, propelling market growth. The region's large population base also provides a vast pool of genetic data, facilitating epigenetic studies. Latin America is witnessing gradual growth, driven by rising investments in healthcare and biotechnology sectors. Brazil and Mexico are at the forefront, with increasing collaborations between research institutions and industry players. The Middle East & Africa region is emerging with growing interest in epigenetics, particularly in addressing region-specific health challenges. Governments are recognizing the potential of epigenetics in improving healthcare outcomes, leading to increased funding and research activities. Overall, the global epigenetics market is poised for significant growth, with regional dynamics shaping its trajectory and offering lucrative opportunities for stakeholders.

Recent Developments:

The epigenetics market has witnessed notable developments over the past three months, reflecting a dynamic landscape of innovation and collaboration. Firstly, Illumina announced a strategic partnership with a leading biotech firm to enhance epigenetic sequencing capabilities, aiming to accelerate research in personalized medicine. Secondly, Thermo Fisher Scientific launched a novel epigenetic analysis platform, promising to revolutionize precision diagnostics with enhanced accuracy and speed. In another significant move, Qiagen completed the acquisition of a cutting-edge epigenetic technology company, strengthening its portfolio in the molecular diagnostics space. Additionally, a joint venture between two prominent pharmaceutical giants was established to explore epigenetic therapies for cancer treatment, highlighting the sector's potential in oncology. Finally, a recent market analysis report projected substantial growth in the epigenetics market, driven by increasing investments in research and development and a surge in demand for targeted therapies. These developments underscore the burgeoning opportunities within the epigenetics domain, poised for transformative impacts on healthcare.

Key Trends and Drivers:

The epigenetics market is experiencing robust growth, driven by advancements in technology, increasing prevalence of cancer, and rising investment in research and development. Key trends include the integration of artificial intelligence and machine learning in epigenetic research, which is enhancing the precision and speed of data analysis. The adoption of personalized medicine is also on the rise, with epigenetic biomarkers playing a crucial role in tailoring treatments to individual patients. Drivers of the market include the growing awareness of the role of epigenetics in disease prevention and management. As more is understood about how environmental factors can influence gene expression, there is an increased demand for epigenetic solutions in healthcare. Additionally, collaborations between academic institutions and biotechnology companies are fostering innovation and expanding the scope of epigenetic applications. The pharmaceutical industry is increasingly focusing on developing epigenetic drugs, which is creating lucrative opportunities for market players. The demand for non-invasive diagnostic techniques is also propelling the market forward. As regulatory bodies provide more favorable guidelines, the path to market entry is becoming smoother, encouraging new entrants and investments. The epigenetics market is poised for continuous expansion, driven by these dynamic trends and drivers.

Restraints and Challenges:

The epigenetics market is navigating through several notable restraints and challenges. A significant hurdle is the high cost of epigenetic research and technology, which limits accessibility to advanced tools and methodologies. This financial barrier is particularly pronounced in developing regions, where funding for cutting-edge research is scarce. Furthermore, the complexity of epigenetic mechanisms requires specialized knowledge, which is not yet widespread among medical professionals, leading to a slower adoption rate. Regulatory hurdles also present a challenge, as epigenetic therapies and diagnostics must comply with rigorous approval processes, potentially delaying market entry. Additionally, the ethical concerns surrounding genetic modification and manipulation can stymie public acceptance and lead to increased scrutiny. Lastly, the rapidly evolving nature of the field necessitates continuous investment in research and development, which can strain resources and create a competitive landscape that favors established players over emerging innovators. These challenges collectively shape the trajectory of the epigenetics market.

Key Companies:

Zymo Research, Active Motif, New England Biolabs, Diagenode, Epigenomics, Abcam, Bio-Rad Laboratories, EpiGentek, Cell Signaling Technology, Selleck Chemicals, PerkinElmer, QIAGEN, Illumina, Meridian Bioscience, Promega Corporation, SABiosciences, Cayman Chemical, Takara Bio, Enzo Life Sciences, Novus Biologicals

Sources:

National Institutes of Health (NIH) - Epigenomics Program, European Molecular Biology Laboratory (EMBL), Wellcome Trust Sanger Institute, International Human Epigenome Consortium (IHEC), National Center for Biotechnology Information (NCBI), National Cancer Institute (NCI) - Center for Cancer Genomics, European Bioinformatics Institute (EMBL-EBI), Human Epigenome Atlas, Epigenetics Society, American Association for Cancer Research (AACR) - Annual Meeting, Society for Neuroscience (SfN) Annual Meeting, Keystone Symposia on Molecular and Cellular Biology - Epigenetics and Chromatin, Gordon Research Conferences - Epigenetic Regulation of Gene Expression, Cold Spring Harbor Laboratory - Epigenetics and Chromatin Conference, International Congress of Genetics, Human Genome Organisation (HUGO) - Human Genomics Meeting, European Union - Horizon 2020 Research and Innovation Programme, U.S. Food and Drug Administration (FDA) - Office of Biotechnology Products, National Science Foundation (NSF), World Health Organization (WHO) - International Agency for Research on Cancer (IARC)

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Epigenetics Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Epigenetics Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Application
  • 2.8 Key Highlights of the Market, by End User
  • 2.9 Key Highlights of the Market, by Component
  • 2.10 Key Highlights of the Market, by Device
  • 2.11 Key Highlights of the Market, by North America
  • 2.12 Key Highlights of the Market, by Europe
  • 2.13 Key Highlights of the Market, by Asia-Pacific
  • 2.14 Key Highlights of the Market, by Latin America
  • 2.15 Key Highlights of the Market, by Middle East
  • 2.16 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Application
  • 3.7 Market Attractiveness Analysis, by End User
  • 3.8 Market Attractiveness Analysis, by Component
  • 3.9 Market Attractiveness Analysis, by Device
  • 3.10 Market Attractiveness Analysis, by North America
  • 3.11 Market Attractiveness Analysis, by Europe
  • 3.12 Market Attractiveness Analysis, by Asia-Pacific
  • 3.13 Market Attractiveness Analysis, by Latin America
  • 3.14 Market Attractiveness Analysis, by Middle East
  • 3.15 Market Attractiveness Analysis, by Africa

4: Epigenetics Market Outlook

  • 4.1 Epigenetics Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Epigenetics Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Epigenetics Market Size

  • 6.1 Epigenetics Market Size, by Value
  • 6.2 Epigenetics Market Size, by Volume

7: Epigenetics Market , by Type

  • 7.1 Market Overview
  • 7.2 DNA Methylation
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Histone Modification
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Non-coding RNA
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Chromatin Remodeling
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Epigenetic Enzymes
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Epigenetic Readers
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Epigenetic Writers
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Epigenetic Erasers
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region
  • 7.10 Others
    • 7.10.1 Key Market Trends & Opportunity Analysis
    • 7.10.2 Market Size and Forecast, by Region

8: Epigenetics Market , by Product

  • 8.1 Market Overview
  • 8.2 Reagents
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Kits
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Instruments
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Enzymes
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Antibodies
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Software
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Others
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region

9: Epigenetics Market , by Services

  • 9.1 Market Overview
  • 9.2 Epigenetic Sequencing
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 DNA Methylation Analysis
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Chromatin Immunoprecipitation
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Bioinformatics Solutions
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Consulting Services
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Others
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region

10: Epigenetics Market , by Technology

  • 10.1 Market Overview
  • 10.2 Next-Generation Sequencing
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 Polymerase Chain Reaction
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Mass Spectrometry
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Chromatin Analysis
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Microarray
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Others
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region

11: Epigenetics Market , by Application

  • 11.1 Market Overview
  • 11.2 Oncology
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Cardiovascular Diseases
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Metabolic Diseases
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Neurodegenerative Diseases
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region
  • 11.6 Immunology
    • 11.6.1 Key Market Trends & Opportunity Analysis
    • 11.6.2 Market Size and Forecast, by Region
  • 11.7 Developmental Biology
    • 11.7.1 Key Market Trends & Opportunity Analysis
    • 11.7.2 Market Size and Forecast, by Region
  • 11.8 Others
    • 11.8.1 Key Market Trends & Opportunity Analysis
    • 11.8.2 Market Size and Forecast, by Region

12: Epigenetics Market , by End User

  • 12.1 Market Overview
  • 12.2 Academic Research Institutes
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Pharmaceutical Companies
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Biotechnology Companies
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Contract Research Organizations
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Clinical Research Laboratories
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Others
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region

13: Epigenetics Market , by Component

  • 13.1 Market Overview
  • 13.2 Assay Kits
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Reagent Kits
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Antibodies
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Others
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region

14: Epigenetics Market , by Device

  • 14.1 Market Overview
  • 14.2 Analytical Instruments
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 Sequencing Platforms
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 Others
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region

15: Epigenetics Market , by Region

  • 15.1 Overview
  • 15.2 North America
    • 15.2.1 Key Market Trends and Opportunities
    • 15.2.2 North America Market Size and Forecast, by Type
    • 15.2.3 North America Market Size and Forecast, by Product
    • 15.2.4 North America Market Size and Forecast, by Services
    • 15.2.5 North America Market Size and Forecast, by Technology
    • 15.2.6 North America Market Size and Forecast, by Application
    • 15.2.7 North America Market Size and Forecast, by End User
    • 15.2.8 North America Market Size and Forecast, by Component
    • 15.2.9 North America Market Size and Forecast, by Device
    • 15.2.10 North America Market Size and Forecast, by Country
    • 15.2.11 United States
      • 15.2.9.1 United States Market Size and Forecast, by Type
      • 15.2.9.2 United States Market Size and Forecast, by Product
      • 15.2.9.3 United States Market Size and Forecast, by Services
      • 15.2.9.4 United States Market Size and Forecast, by Technology
      • 15.2.9.5 United States Market Size and Forecast, by Application
      • 15.2.9.6 United States Market Size and Forecast, by End User
      • 15.2.9.7 United States Market Size and Forecast, by Component
      • 15.2.9.8 United States Market Size and Forecast, by Device
      • 15.2.9.9 Local Competition Analysis
      • 15.2.9.10 Local Market Analysis
    • 15.2.1 Canada
      • 15.2.10.1 Canada Market Size and Forecast, by Type
      • 15.2.10.2 Canada Market Size and Forecast, by Product
      • 15.2.10.3 Canada Market Size and Forecast, by Services
      • 15.2.10.4 Canada Market Size and Forecast, by Technology
      • 15.2.10.5 Canada Market Size and Forecast, by Application
      • 15.2.10.6 Canada Market Size and Forecast, by End User
      • 15.2.10.7 Canada Market Size and Forecast, by Component
      • 15.2.10.8 Canada Market Size and Forecast, by Device
      • 15.2.10.9 Local Competition Analysis
      • 15.2.10.10 Local Market Analysis
  • 15.1 Europe
    • 15.3.1 Key Market Trends and Opportunities
    • 15.3.2 Europe Market Size and Forecast, by Type
    • 15.3.3 Europe Market Size and Forecast, by Product
    • 15.3.4 Europe Market Size and Forecast, by Services
    • 15.3.5 Europe Market Size and Forecast, by Technology
    • 15.3.6 Europe Market Size and Forecast, by Application
    • 15.3.7 Europe Market Size and Forecast, by End User
    • 15.3.8 Europe Market Size and Forecast, by Component
    • 15.3.9 Europe Market Size and Forecast, by Device
    • 15.3.10 Europe Market Size and Forecast, by Country
    • 15.3.11 United Kingdom
      • 15.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 15.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 15.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 15.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 15.3.9.5 United Kingdom Market Size and Forecast, by Application
      • 15.3.9.6 United Kingdom Market Size and Forecast, by End User
      • 15.3.9.7 United Kingdom Market Size and Forecast, by Component
      • 15.3.9.8 United Kingdom Market Size and Forecast, by Device
      • 15.3.9.9 Local Competition Analysis
      • 15.3.9.10 Local Market Analysis
    • 15.3.1 Germany
      • 15.3.10.1 Germany Market Size and Forecast, by Type
      • 15.3.10.2 Germany Market Size and Forecast, by Product
      • 15.3.10.3 Germany Market Size and Forecast, by Services
      • 15.3.10.4 Germany Market Size and Forecast, by Technology
      • 15.3.10.5 Germany Market Size and Forecast, by Application
      • 15.3.10.6 Germany Market Size and Forecast, by End User
      • 15.3.10.7 Germany Market Size and Forecast, by Component
      • 15.3.10.8 Germany Market Size and Forecast, by Device
      • 15.3.10.9 Local Competition Analysis
      • 15.3.10.10 Local Market Analysis
    • 15.3.1 France
      • 15.3.11.1 France Market Size and Forecast, by Type
      • 15.3.11.2 France Market Size and Forecast, by Product
      • 15.3.11.3 France Market Size and Forecast, by Services
      • 15.3.11.4 France Market Size and Forecast, by Technology
      • 15.3.11.5 France Market Size and Forecast, by Application
      • 15.3.11.6 France Market Size and Forecast, by End User
      • 15.3.11.7 France Market Size and Forecast, by Component
      • 15.3.11.8 France Market Size and Forecast, by Device
      • 15.3.11.9 Local Competition Analysis
      • 15.3.11.10 Local Market Analysis
    • 15.3.1 Spain
      • 15.3.12.1 Spain Market Size and Forecast, by Type
      • 15.3.12.2 Spain Market Size and Forecast, by Product
      • 15.3.12.3 Spain Market Size and Forecast, by Services
      • 15.3.12.4 Spain Market Size and Forecast, by Technology
      • 15.3.12.5 Spain Market Size and Forecast, by Application
      • 15.3.12.6 Spain Market Size and Forecast, by End User
      • 15.3.12.7 Spain Market Size and Forecast, by Component
      • 15.3.12.8 Spain Market Size and Forecast, by Device
      • 15.3.12.9 Local Competition Analysis
      • 15.3.12.10 Local Market Analysis
    • 15.3.1 Italy
      • 15.3.13.1 Italy Market Size and Forecast, by Type
      • 15.3.13.2 Italy Market Size and Forecast, by Product
      • 15.3.13.3 Italy Market Size and Forecast, by Services
      • 15.3.13.4 Italy Market Size and Forecast, by Technology
      • 15.3.13.5 Italy Market Size and Forecast, by Application
      • 15.3.13.6 Italy Market Size and Forecast, by End User
      • 15.3.13.7 Italy Market Size and Forecast, by Component
      • 15.3.13.8 Italy Market Size and Forecast, by Device
      • 15.3.13.9 Local Competition Analysis
      • 15.3.13.10 Local Market Analysis
    • 15.3.1 Netherlands
      • 15.3.14.1 Netherlands Market Size and Forecast, by Type
      • 15.3.14.2 Netherlands Market Size and Forecast, by Product
      • 15.3.14.3 Netherlands Market Size and Forecast, by Services
      • 15.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 15.3.14.5 Netherlands Market Size and Forecast, by Application
      • 15.3.14.6 Netherlands Market Size and Forecast, by End User
      • 15.3.14.7 Netherlands Market Size and Forecast, by Component
      • 15.3.14.8 Netherlands Market Size and Forecast, by Device
      • 15.3.14.9 Local Competition Analysis
      • 15.3.14.10 Local Market Analysis
    • 15.3.1 Sweden
      • 15.3.15.1 Sweden Market Size and Forecast, by Type
      • 15.3.15.2 Sweden Market Size and Forecast, by Product
      • 15.3.15.3 Sweden Market Size and Forecast, by Services
      • 15.3.15.4 Sweden Market Size and Forecast, by Technology
      • 15.3.15.5 Sweden Market Size and Forecast, by Application
      • 15.3.15.6 Sweden Market Size and Forecast, by End User
      • 15.3.15.7 Sweden Market Size and Forecast, by Component
      • 15.3.15.8 Sweden Market Size and Forecast, by Device
      • 15.3.15.9 Local Competition Analysis
      • 15.3.15.10 Local Market Analysis
    • 15.3.1 Switzerland
      • 15.3.16.1 Switzerland Market Size and Forecast, by Type
      • 15.3.16.2 Switzerland Market Size and Forecast, by Product
      • 15.3.16.3 Switzerland Market Size and Forecast, by Services
      • 15.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 15.3.16.5 Switzerland Market Size and Forecast, by Application
      • 15.3.16.6 Switzerland Market Size and Forecast, by End User
      • 15.3.16.7 Switzerland Market Size and Forecast, by Component
      • 15.3.16.8 Switzerland Market Size and Forecast, by Device
      • 15.3.16.9 Local Competition Analysis
      • 15.3.16.10 Local Market Analysis
    • 15.3.1 Denmark
      • 15.3.17.1 Denmark Market Size and Forecast, by Type
      • 15.3.17.2 Denmark Market Size and Forecast, by Product
      • 15.3.17.3 Denmark Market Size and Forecast, by Services
      • 15.3.17.4 Denmark Market Size and Forecast, by Technology
      • 15.3.17.5 Denmark Market Size and Forecast, by Application
      • 15.3.17.6 Denmark Market Size and Forecast, by End User
      • 15.3.17.7 Denmark Market Size and Forecast, by Component
      • 15.3.17.8 Denmark Market Size and Forecast, by Device
      • 15.3.17.9 Local Competition Analysis
      • 15.3.17.10 Local Market Analysis
    • 15.3.1 Finland
      • 15.3.18.1 Finland Market Size and Forecast, by Type
      • 15.3.18.2 Finland Market Size and Forecast, by Product
      • 15.3.18.3 Finland Market Size and Forecast, by Services
      • 15.3.18.4 Finland Market Size and Forecast, by Technology
      • 15.3.18.5 Finland Market Size and Forecast, by Application
      • 15.3.18.6 Finland Market Size and Forecast, by End User
      • 15.3.18.7 Finland Market Size and Forecast, by Component
      • 15.3.18.8 Finland Market Size and Forecast, by Device
      • 15.3.18.9 Local Competition Analysis
      • 15.3.18.10 Local Market Analysis
    • 15.3.1 Russia
      • 15.3.19.1 Russia Market Size and Forecast, by Type
      • 15.3.19.2 Russia Market Size and Forecast, by Product
      • 15.3.19.3 Russia Market Size and Forecast, by Services
      • 15.3.19.4 Russia Market Size and Forecast, by Technology
      • 15.3.19.5 Russia Market Size and Forecast, by Application
      • 15.3.19.6 Russia Market Size and Forecast, by End User
      • 15.3.19.7 Russia Market Size and Forecast, by Component
      • 15.3.19.8 Russia Market Size and Forecast, by Device
      • 15.3.19.9 Local Competition Analysis
      • 15.3.19.10 Local Market Analysis
    • 15.3.1 Rest of Europe
      • 15.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 15.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 15.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 15.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 15.3.20.5 Rest of Europe Market Size and Forecast, by Application
      • 15.3.20.6 Rest of Europe Market Size and Forecast, by End User
      • 15.3.20.7 Rest of Europe Market Size and Forecast, by Component
      • 15.3.20.8 Rest of Europe Market Size and Forecast, by Device
      • 15.3.20.9 Local Competition Analysis
      • 15.3.20.10 Local Market Analysis
  • 15.1 Asia-Pacific
    • 15.4.1 Key Market Trends and Opportunities
    • 15.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 15.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 15.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 15.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 15.4.6 Asia-Pacific Market Size and Forecast, by Application
    • 15.4.7 Asia-Pacific Market Size and Forecast, by End User
    • 15.4.8 Asia-Pacific Market Size and Forecast, by Component
    • 15.4.9 Asia-Pacific Market Size and Forecast, by Device
    • 15.4.10 Asia-Pacific Market Size and Forecast, by Country
    • 15.4.11 China
      • 15.4.9.1 China Market Size and Forecast, by Type
      • 15.4.9.2 China Market Size and Forecast, by Product
      • 15.4.9.3 China Market Size and Forecast, by Services
      • 15.4.9.4 China Market Size and Forecast, by Technology
      • 15.4.9.5 China Market Size and Forecast, by Application
      • 15.4.9.6 China Market Size and Forecast, by End User
      • 15.4.9.7 China Market Size and Forecast, by Component
      • 15.4.9.8 China Market Size and Forecast, by Device
      • 15.4.9.9 Local Competition Analysis
      • 15.4.9.10 Local Market Analysis
    • 15.4.1 India
      • 15.4.10.1 India Market Size and Forecast, by Type
      • 15.4.10.2 India Market Size and Forecast, by Product
      • 15.4.10.3 India Market Size and Forecast, by Services
      • 15.4.10.4 India Market Size and Forecast, by Technology
      • 15.4.10.5 India Market Size and Forecast, by Application
      • 15.4.10.6 India Market Size and Forecast, by End User
      • 15.4.10.7 India Market Size and Forecast, by Component
      • 15.4.10.8 India Market Size and Forecast, by Device
      • 15.4.10.9 Local Competition Analysis
      • 15.4.10.10 Local Market Analysis
    • 15.4.1 Japan
      • 15.4.11.1 Japan Market Size and Forecast, by Type
      • 15.4.11.2 Japan Market Size and Forecast, by Product
      • 15.4.11.3 Japan Market Size and Forecast, by Services
      • 15.4.11.4 Japan Market Size and Forecast, by Technology
      • 15.4.11.5 Japan Market Size and Forecast, by Application
      • 15.4.11.6 Japan Market Size and Forecast, by End User
      • 15.4.11.7 Japan Market Size and Forecast, by Component
      • 15.4.11.8 Japan Market Size and Forecast, by Device
      • 15.4.11.9 Local Competition Analysis
      • 15.4.11.10 Local Market Analysis
    • 15.4.1 South Korea
      • 15.4.12.1 South Korea Market Size and Forecast, by Type
      • 15.4.12.2 South Korea Market Size and Forecast, by Product
      • 15.4.12.3 South Korea Market Size and Forecast, by Services
      • 15.4.12.4 South Korea Market Size and Forecast, by Technology
      • 15.4.12.5 South Korea Market Size and Forecast, by Application
      • 15.4.12.6 South Korea Market Size and Forecast, by End User
      • 15.4.12.7 South Korea Market Size and Forecast, by Component
      • 15.4.12.8 South Korea Market Size and Forecast, by Device
      • 15.4.12.9 Local Competition Analysis
      • 15.4.12.10 Local Market Analysis
    • 15.4.1 Australia
      • 15.4.13.1 Australia Market Size and Forecast, by Type
      • 15.4.13.2 Australia Market Size and Forecast, by Product
      • 15.4.13.3 Australia Market Size and Forecast, by Services
      • 15.4.13.4 Australia Market Size and Forecast, by Technology
      • 15.4.13.5 Australia Market Size and Forecast, by Application
      • 15.4.13.6 Australia Market Size and Forecast, by End User
      • 15.4.13.7 Australia Market Size and Forecast, by Component
      • 15.4.13.8 Australia Market Size and Forecast, by Device
      • 15.4.13.9 Local Competition Analysis
      • 15.4.13.10 Local Market Analysis
    • 15.4.1 Singapore
      • 15.4.14.1 Singapore Market Size and Forecast, by Type
      • 15.4.14.2 Singapore Market Size and Forecast, by Product
      • 15.4.14.3 Singapore Market Size and Forecast, by Services
      • 15.4.14.4 Singapore Market Size and Forecast, by Technology
      • 15.4.14.5 Singapore Market Size and Forecast, by Application
      • 15.4.14.6 Singapore Market Size and Forecast, by End User
      • 15.4.14.7 Singapore Market Size and Forecast, by Component
      • 15.4.14.8 Singapore Market Size and Forecast, by Device
      • 15.4.14.9 Local Competition Analysis
      • 15.4.14.10 Local Market Analysis
    • 15.4.1 Indonesia
      • 15.4.15.1 Indonesia Market Size and Forecast, by Type
      • 15.4.15.2 Indonesia Market Size and Forecast, by Product
      • 15.4.15.3 Indonesia Market Size and Forecast, by Services
      • 15.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 15.4.15.5 Indonesia Market Size and Forecast, by Application
      • 15.4.15.6 Indonesia Market Size and Forecast, by End User
      • 15.4.15.7 Indonesia Market Size and Forecast, by Component
      • 15.4.15.8 Indonesia Market Size and Forecast, by Device
      • 15.4.15.9 Local Competition Analysis
      • 15.4.15.10 Local Market Analysis
    • 15.4.1 Taiwan
      • 15.4.16.1 Taiwan Market Size and Forecast, by Type
      • 15.4.16.2 Taiwan Market Size and Forecast, by Product
      • 15.4.16.3 Taiwan Market Size and Forecast, by Services
      • 15.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 15.4.16.5 Taiwan Market Size and Forecast, by Application
      • 15.4.16.6 Taiwan Market Size and Forecast, by End User
      • 15.4.16.7 Taiwan Market Size and Forecast, by Component
      • 15.4.16.8 Taiwan Market Size and Forecast, by Device
      • 15.4.16.9 Local Competition Analysis
      • 15.4.16.10 Local Market Analysis
    • 15.4.1 Malaysia
      • 15.4.17.1 Malaysia Market Size and Forecast, by Type
      • 15.4.17.2 Malaysia Market Size and Forecast, by Product
      • 15.4.17.3 Malaysia Market Size and Forecast, by Services
      • 15.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 15.4.17.5 Malaysia Market Size and Forecast, by Application
      • 15.4.17.6 Malaysia Market Size and Forecast, by End User
      • 15.4.17.7 Malaysia Market Size and Forecast, by Component
      • 15.4.17.8 Malaysia Market Size and Forecast, by Device
      • 15.4.17.9 Local Competition Analysis
      • 15.4.17.10 Local Market Analysis
    • 15.4.1 Rest of Asia-Pacific
      • 15.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 15.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 15.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 15.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 15.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 15.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 15.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 15.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 15.4.18.9 Local Competition Analysis
      • 15.4.18.10 Local Market Analysis
  • 15.1 Latin America
    • 15.5.1 Key Market Trends and Opportunities
    • 15.5.2 Latin America Market Size and Forecast, by Type
    • 15.5.3 Latin America Market Size and Forecast, by Product
    • 15.5.4 Latin America Market Size and Forecast, by Services
    • 15.5.5 Latin America Market Size and Forecast, by Technology
    • 15.5.6 Latin America Market Size and Forecast, by Application
    • 15.5.7 Latin America Market Size and Forecast, by End User
    • 15.5.8 Latin America Market Size and Forecast, by Component
    • 15.5.9 Latin America Market Size and Forecast, by Device
    • 15.5.10 Latin America Market Size and Forecast, by Country
    • 15.5.11 Brazil
      • 15.5.9.1 Brazil Market Size and Forecast, by Type
      • 15.5.9.2 Brazil Market Size and Forecast, by Product
      • 15.5.9.3 Brazil Market Size and Forecast, by Services
      • 15.5.9.4 Brazil Market Size and Forecast, by Technology
      • 15.5.9.5 Brazil Market Size and Forecast, by Application
      • 15.5.9.6 Brazil Market Size and Forecast, by End User
      • 15.5.9.7 Brazil Market Size and Forecast, by Component
      • 15.5.9.8 Brazil Market Size and Forecast, by Device
      • 15.5.9.9 Local Competition Analysis
      • 15.5.9.10 Local Market Analysis
    • 15.5.1 Mexico
      • 15.5.10.1 Mexico Market Size and Forecast, by Type
      • 15.5.10.2 Mexico Market Size and Forecast, by Product
      • 15.5.10.3 Mexico Market Size and Forecast, by Services
      • 15.5.10.4 Mexico Market Size and Forecast, by Technology
      • 15.5.10.5 Mexico Market Size and Forecast, by Application
      • 15.5.10.6 Mexico Market Size and Forecast, by End User
      • 15.5.10.7 Mexico Market Size and Forecast, by Component
      • 15.5.10.8 Mexico Market Size and Forecast, by Device
      • 15.5.10.9 Local Competition Analysis
      • 15.5.10.10 Local Market Analysis
    • 15.5.1 Argentina
      • 15.5.11.1 Argentina Market Size and Forecast, by Type
      • 15.5.11.2 Argentina Market Size and Forecast, by Product
      • 15.5.11.3 Argentina Market Size and Forecast, by Services
      • 15.5.11.4 Argentina Market Size and Forecast, by Technology
      • 15.5.11.5 Argentina Market Size and Forecast, by Application
      • 15.5.11.6 Argentina Market Size and Forecast, by End User
      • 15.5.11.7 Argentina Market Size and Forecast, by Component
      • 15.5.11.8 Argentina Market Size and Forecast, by Device
      • 15.5.11.9 Local Competition Analysis
      • 15.5.11.10 Local Market Analysis
    • 15.5.1 Rest of Latin America
      • 15.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 15.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 15.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 15.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 15.5.12.5 Rest of Latin America Market Size and Forecast, by Application
      • 15.5.12.6 Rest of Latin America Market Size and Forecast, by End User
      • 15.5.12.7 Rest of Latin America Market Size and Forecast, by Component
      • 15.5.12.8 Rest of Latin America Market Size and Forecast, by Device
      • 15.5.12.9 Local Competition Analysis
      • 15.5.12.10 Local Market Analysis
  • 15.1 Middle East and Africa
    • 15.6.1 Key Market Trends and Opportunities
    • 15.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 15.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 15.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 15.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 15.6.6 Middle East and Africa Market Size and Forecast, by Application
    • 15.6.7 Middle East and Africa Market Size and Forecast, by End User
    • 15.6.8 Middle East and Africa Market Size and Forecast, by Component
    • 15.6.9 Middle East and Africa Market Size and Forecast, by Device
    • 15.6.10 Middle East and Africa Market Size and Forecast, by Country
    • 15.6.11 Saudi Arabia
      • 15.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 15.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 15.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 15.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 15.6.9.5 Saudi Arabia Market Size and Forecast, by Application
      • 15.6.9.6 Saudi Arabia Market Size and Forecast, by End User
      • 15.6.9.7 Saudi Arabia Market Size and Forecast, by Component
      • 15.6.9.8 Saudi Arabia Market Size and Forecast, by Device
      • 15.6.9.9 Local Competition Analysis
      • 15.6.9.10 Local Market Analysis
    • 15.6.1 UAE
      • 15.6.10.1 UAE Market Size and Forecast, by Type
      • 15.6.10.2 UAE Market Size and Forecast, by Product
      • 15.6.10.3 UAE Market Size and Forecast, by Services
      • 15.6.10.4 UAE Market Size and Forecast, by Technology
      • 15.6.10.5 UAE Market Size and Forecast, by Application
      • 15.6.10.6 UAE Market Size and Forecast, by End User
      • 15.6.10.7 UAE Market Size and Forecast, by Component
      • 15.6.10.8 UAE Market Size and Forecast, by Device
      • 15.6.10.9 Local Competition Analysis
      • 15.6.10.10 Local Market Analysis
    • 15.6.1 South Africa
      • 15.6.11.1 South Africa Market Size and Forecast, by Type
      • 15.6.11.2 South Africa Market Size and Forecast, by Product
      • 15.6.11.3 South Africa Market Size and Forecast, by Services
      • 15.6.11.4 South Africa Market Size and Forecast, by Technology
      • 15.6.11.5 South Africa Market Size and Forecast, by Application
      • 15.6.11.6 South Africa Market Size and Forecast, by End User
      • 15.6.11.7 South Africa Market Size and Forecast, by Component
      • 15.6.11.8 South Africa Market Size and Forecast, by Device
      • 15.6.11.9 Local Competition Analysis
      • 15.6.11.10 Local Market Analysis
    • 15.6.1 Rest of MEA
      • 15.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 15.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 15.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 15.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 15.6.12.5 Rest of MEA Market Size and Forecast, by Application
      • 15.6.12.6 Rest of MEA Market Size and Forecast, by End User
      • 15.6.12.7 Rest of MEA Market Size and Forecast, by Component
      • 15.6.12.8 Rest of MEA Market Size and Forecast, by Device
      • 15.6.12.9 Local Competition Analysis
      • 15.6.12.10 Local Market Analysis

16: Competitive Landscape

  • 16.1 Overview
  • 16.2 Market Share Analysis
  • 16.3 Key Player Positioning
  • 16.4 Competitive Leadership Mapping
    • 16.4.1 Star Players
    • 16.4.2 Innovators
    • 16.4.3 Emerging Players
  • 16.5 Vendor Benchmarking
  • 16.6 Developmental Strategy Benchmarking
    • 16.6.1 New Product Developments
    • 16.6.2 Product Launches
    • 16.6.3 Business Expansions
    • 16.6.4 Partnerships, Joint Ventures, and Collaborations
    • 16.6.5 Mergers and Acquisitions

17: Company Profiles

  • 17.1 Zymo Research
    • 17.1.1 Company Overview
    • 17.1.2 Company Snapshot
    • 17.1.3 Business Segments
    • 17.1.4 Business Performance
    • 17.1.5 Product Offerings
    • 17.1.6 Key Developmental Strategies
    • 17.1.7 SWOT Analysis
  • 17.2 Active Motif
    • 17.2.1 Company Overview
    • 17.2.2 Company Snapshot
    • 17.2.3 Business Segments
    • 17.2.4 Business Performance
    • 17.2.5 Product Offerings
    • 17.2.6 Key Developmental Strategies
    • 17.2.7 SWOT Analysis
  • 17.3 New England Biolabs
    • 17.3.1 Company Overview
    • 17.3.2 Company Snapshot
    • 17.3.3 Business Segments
    • 17.3.4 Business Performance
    • 17.3.5 Product Offerings
    • 17.3.6 Key Developmental Strategies
    • 17.3.7 SWOT Analysis
  • 17.4 Diagenode
    • 17.4.1 Company Overview
    • 17.4.2 Company Snapshot
    • 17.4.3 Business Segments
    • 17.4.4 Business Performance
    • 17.4.5 Product Offerings
    • 17.4.6 Key Developmental Strategies
    • 17.4.7 SWOT Analysis
  • 17.5 Epigenomics
    • 17.5.1 Company Overview
    • 17.5.2 Company Snapshot
    • 17.5.3 Business Segments
    • 17.5.4 Business Performance
    • 17.5.5 Product Offerings
    • 17.5.6 Key Developmental Strategies
    • 17.5.7 SWOT Analysis
  • 17.6 Abcam
    • 17.6.1 Company Overview
    • 17.6.2 Company Snapshot
    • 17.6.3 Business Segments
    • 17.6.4 Business Performance
    • 17.6.5 Product Offerings
    • 17.6.6 Key Developmental Strategies
    • 17.6.7 SWOT Analysis
  • 17.7 Bio-Rad Laboratories
    • 17.7.1 Company Overview
    • 17.7.2 Company Snapshot
    • 17.7.3 Business Segments
    • 17.7.4 Business Performance
    • 17.7.5 Product Offerings
    • 17.7.6 Key Developmental Strategies
    • 17.7.7 SWOT Analysis
  • 17.8 EpiGentek
    • 17.8.1 Company Overview
    • 17.8.2 Company Snapshot
    • 17.8.3 Business Segments
    • 17.8.4 Business Performance
    • 17.8.5 Product Offerings
    • 17.8.6 Key Developmental Strategies
    • 17.8.7 SWOT Analysis
  • 17.9 Cell Signaling Technology
    • 17.9.1 Company Overview
    • 17.9.2 Company Snapshot
    • 17.9.3 Business Segments
    • 17.9.4 Business Performance
    • 17.9.5 Product Offerings
    • 17.9.6 Key Developmental Strategies
    • 17.9.7 SWOT Analysis
  • 17.10 Selleck Chemicals
    • 17.10.1 Company Overview
    • 17.10.2 Company Snapshot
    • 17.10.3 Business Segments
    • 17.10.4 Business Performance
    • 17.10.5 Product Offerings
    • 17.10.6 Key Developmental Strategies
    • 17.10.7 SWOT Analysis
  • 17.11 PerkinElmer
    • 17.11.1 Company Overview
    • 17.11.2 Company Snapshot
    • 17.11.3 Business Segments
    • 17.11.4 Business Performance
    • 17.11.5 Product Offerings
    • 17.11.6 Key Developmental Strategies
    • 17.11.7 SWOT Analysis
  • 17.12 QIAGEN
    • 17.12.1 Company Overview
    • 17.12.2 Company Snapshot
    • 17.12.3 Business Segments
    • 17.12.4 Business Performance
    • 17.12.5 Product Offerings
    • 17.12.6 Key Developmental Strategies
    • 17.12.7 SWOT Analysis
  • 17.13 Illumina
    • 17.13.1 Company Overview
    • 17.13.2 Company Snapshot
    • 17.13.3 Business Segments
    • 17.13.4 Business Performance
    • 17.13.5 Product Offerings
    • 17.13.6 Key Developmental Strategies
    • 17.13.7 SWOT Analysis
  • 17.14 Meridian Bioscience
    • 17.14.1 Company Overview
    • 17.14.2 Company Snapshot
    • 17.14.3 Business Segments
    • 17.14.4 Business Performance
    • 17.14.5 Product Offerings
    • 17.14.6 Key Developmental Strategies
    • 17.14.7 SWOT Analysis
  • 17.15 Promega Corporation
    • 17.15.1 Company Overview
    • 17.15.2 Company Snapshot
    • 17.15.3 Business Segments
    • 17.15.4 Business Performance
    • 17.15.5 Product Offerings
    • 17.15.6 Key Developmental Strategies
    • 17.15.7 SWOT Analysis
  • 17.16 SABiosciences
    • 17.16.1 Company Overview
    • 17.16.2 Company Snapshot
    • 17.16.3 Business Segments
    • 17.16.4 Business Performance
    • 17.16.5 Product Offerings
    • 17.16.6 Key Developmental Strategies
    • 17.16.7 SWOT Analysis
  • 17.17 Cayman Chemical
    • 17.17.1 Company Overview
    • 17.17.2 Company Snapshot
    • 17.17.3 Business Segments
    • 17.17.4 Business Performance
    • 17.17.5 Product Offerings
    • 17.17.6 Key Developmental Strategies
    • 17.17.7 SWOT Analysis
  • 17.18 Takara Bio
    • 17.18.1 Company Overview
    • 17.18.2 Company Snapshot
    • 17.18.3 Business Segments
    • 17.18.4 Business Performance
    • 17.18.5 Product Offerings
    • 17.18.6 Key Developmental Strategies
    • 17.18.7 SWOT Analysis
  • 17.19 Enzo Life Sciences
    • 17.19.1 Company Overview
    • 17.19.2 Company Snapshot
    • 17.19.3 Business Segments
    • 17.19.4 Business Performance
    • 17.19.5 Product Offerings
    • 17.19.6 Key Developmental Strategies
    • 17.19.7 SWOT Analysis
  • 17.20 Novus Biologicals
    • 17.20.1 Company Overview
    • 17.20.2 Company Snapshot
    • 17.20.3 Business Segments
    • 17.20.4 Business Performance
    • 17.20.5 Product Offerings
    • 17.20.6 Key Developmental Strategies
    • 17.20.7 SWOT Analysis
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제